Aytu BioPharma, Inc.

3.28 USD
+0.28 (+9.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aytu BioPharma, Inc. stock is up 19.27% since 30 days ago. The next earnings date is May 9, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 February’s closed higher than January.

About Aytu BioPharma, Inc.

Aytu Biopharma, Inc. focuses on developing and commercializing novel therapeutics and consumer healthcare products. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the. treatment of seasonal and perennial allergies.